|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 688.00 GBX | +0.15% |
|
+4.88% | +5.04% |
| 01-04 | Victrex plc Appoints James Mathew Routh as Director, Effective January 1, 2026 | CI |
| 12-16 | Goldman starts Big Yellow; Shore starts Savills | AN |
Business description: Victrex plc
Number of employees: 1,169
Sales by Activity: Victrex plc
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Sustainable Solutions | 257M | 286M | 250M | 241M | 240M |
Medical | 51.1M | 58.3M | 65.2M | 53M | 58.8M |
Internal Revenue | -2.2M | -3.1M | -8.5M | -2.6M | -5.6M |
Geographical breakdown of sales: Victrex plc
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Europe, The Middle East and Africa (EMEA) | 139M | 144M | 128M | 129M | 124M |
Asia-Pacific | 85.9M | 97.9M | 92.5M | 86.3M | 88.2M |
Americas | 77.4M | 94.5M | 82.7M | 72.8M | 74.9M |
United Kingdom | 3.7M | 4.3M | 4.2M | 3.1M | 5.1M |
Executive Committee: Victrex plc
| Manager | Title | Age | Since |
|---|---|---|---|
James Routh
CEO | Chief Executive Officer | 53 | 31/12/2025 |
Ian Melling
DFI | Director of Finance/CFO | - | 03/07/2022 |
Michael Ward
DFI | Director of Finance/CFO | - | - |
Andrew Hanson
IRC | Investor Relations Contact | - | - |
Jane Brisley
LAW | General Counsel | - | 30/06/2021 |
Composition of the Board of Directors: Victrex plc
| Director | Title | Age | Since |
|---|---|---|---|
Jakob Sigurðsson
BRD | Director/Board Member | 62 | 30/09/2017 |
Janet Ashdown
BRD | Director/Board Member | 67 | 08/02/2018 |
Brendan Connolly
BRD | Director/Board Member | 70 | 08/02/2018 |
David Thomas
BRD | Director/Board Member | 71 | 13/05/2018 |
Rosalind Rivaz
BRD | Director/Board Member | 70 | 30/04/2020 |
Dame Cox
CHM | Chairman | 65 | 10/02/2022 |
Ian Melling
BRD | Director/Board Member | - | 03/07/2022 |
| Director/Board Member | - | 30/04/2024 | |
James Routh
BRD | Director/Board Member | 53 | 31/12/2025 |
Company details: Victrex plc
Victrex Plc
Victrex Technology Centre
FY5 4QD, Thornton Cleveleys
+44 12 5389 7700
http://www.victrex.com
Group companies: Victrex plc
| Name | Category and Sector |
|---|---|
Invibio Ltd.
 Invibio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies biomaterial solutions for the implantable medical devices |
Pharmaceuticals: Major
|
Invibio Ltd.
Invibio Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies biomaterial solutions for the implantable medical devices |
Pharmaceuticals: Major
|
Victrex Manufacturing Ltd.
 Victrex Manufacturing Ltd. Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic products |
Miscellaneous Manufacturing
|
Victrex Manufacturing Ltd.
Victrex Manufacturing Ltd. Miscellaneous ManufacturingProducer Manufacturing Manufactures plastic products |
Miscellaneous Manufacturing
|
Other Specialty Chemicals
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | +4.88% | -31.61% | -60.75% | 805M | |
| +0.42% | +0.20% | +16.54% | +76.18% | 76.76B | |
| 0.00% | +2.90% | -17.73% | +6.00% | 37.04B | |
| -9.50% | -8.92% | -31.42% | -39.59% | 33.19B | |
| +1.09% | -1.88% | +1.96% | +49.37% | 25.16B | |
| +4.01% | +8.77% | +108.41% | -3.11% | 22.21B | |
| +4.07% | +11.35% | +92.44% | -27.30% | 19.93B | |
| 0.00% | +3.45% | -7.40% | -14.82% | 16.71B | |
| +3.17% | +0.59% | +42.67% | +140.37% | 15.47B | |
| +5.05% | +9.51% | -25.28% | -27.61% | 11.56B | |
| Average | +0.84% | +4.21% | +14.86% | +9.88% | 25.88B | |
| Weighted average by Cap. | +0.11% | +3.69% | +15.79% | +26.81% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VCT Stock
- Company Victrex plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition